Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚น326.87 B
Marketcap
โ‚น16,608
Share price
-1.93%
Change (1 day)
57.14%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): โ‚น6.17 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.25 Billion. In 2024 the company made an earning of โ‚น0.49 Billion a decrease over its 2023 earnings that were of โ‚น5.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น6.17 B1138.98%
2024 โ‚น0.49 B-91.37%
2023 โ‚น5.77 B-7.59%
2022 โ‚น6.25 B4%
2021 โ‚น6.01 B296.42%
2020 โ‚น1.51 B-97.97%
2019 โ‚น74.77 B275.62%
2018 โ‚น19.90 B237.48%
2017 โ‚น5.89 B49.05%
2016 โ‚น3.95 B55.41%
2015 โ‚น2.54 B36.87%
2014 โ‚น1.86 B29.59%
2013 โ‚น1.43 B1309.35%
2012 โ‚น0.10 B-43.97%
2011 โ‚น0.18 B-113.19%
2010 -โ‚น1.38 Billion59.86%
2009 -โ‚น0.87 Billion-61.33%
2008 -โ‚น2.24 Billion-58.75%
2007 -โ‚น5.41 Billion20.52%
2006 -โ‚น4.49 Billion81.27%
2005 -โ‚น2.48 Billion
2003 -โ‚น1.73 Billion-20.6%
2002 -โ‚น2.17 Billion4.38%
2001 -โ‚น2.08 Billion-48.83%
2000 -โ‚น4.07 Billion-19.74%
1999 -โ‚น5.07 Billion-19.06%
1998 -โ‚น6.26 Billion126.71%
1997 -โ‚น2.76 Billion-5.83%
1996 -โ‚น2.93 Billion136.23%
1995 -โ‚น1.24 Billion-33.97%
1994 -โ‚น1.88 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น740.61 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น5.56 Billion-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น837.53 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น2.074 T 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.021 T 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.65 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น24.26 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.910 T 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA